{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Antioxidants", "Astaxanthin", "Cancer", "Chemotherapy", "Drug delivery", "Green Chemistry", "Nanoparticles"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37179259", "DateCompleted": {"Year": "2023", "Month": "07", "Day": "28"}, "DateRevised": {"Year": "2023", "Month": "07", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "05", "Day": "13"}], "Language": ["eng"], "ELocationID": ["10.1007/s43440-023-00488-y"], "Journal": {"ISSN": "2299-5684", "JournalIssue": {"Volume": "75", "Issue": "4", "PubDate": {"Year": "2023", "Month": "Aug"}}, "Title": "Pharmacological reports : PR", "ISOAbbreviation": "Pharmacol Rep"}, "ArticleTitle": "Production and therapeutic use of astaxanthin in the nanotechnology era.", "Pagination": {"StartPage": "771", "EndPage": "790", "MedlinePgn": "771-790"}, "Abstract": {"AbstractText": ["Astaxanthin (AXT) is a red fat-soluble pigment found naturally in aquatic animals, plants, and various microorganisms and can be manufactured artificially using chemical catalysis. AXT is a xanthophyll carotenoid with a high potential for scavenging free radicals. Several studies have investigated AXT efficacy against diseases such as neurodegenerative, ocular, skin, and cardiovascular hypertension, diabetes, gastrointestinal and liver diseases, and immuno-protective functions. However, its poor solubility, low stability to light and oxygen, and limited bioavailability are major obstacles hindering its wide applications as a therapeutic agent or nutritional supplement. Incorporating AXT with nanocarriers holds great promise in enhancing its physiochemical properties. Nanocarriers are delivery systems with several benefits, including surface modification, bioactivity, and targeted medication delivery and release. Many approaches have been applied to enhance AXT's medicinal effect, including solid lipid nanoparticles, nanostructured lipid carriers (NLCs) and polymeric nanospheres. AXT nano-formulations have demonstrated a high antioxidant and anti-inflammatory effect, significantly affecting cancer in different organs. This review summarizes the most recent data on AXT production, characterization, biological activity, and therapeutic usage, focusing on its uses in the nanotechnology era."], "CopyrightInformation": "\u00a9 2023. The Author(s)."}, "AuthorList": [{"Identifier": ["0000-0001-6598-9188"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Alexandria, Egypt."}], "LastName": "Abdelazim", "ForeName": "Karim", "Initials": "K"}, {"Identifier": ["0000-0002-7153-2413"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Alexandria, Egypt."}, {"Identifier": [], "Affiliation": "Department of Medicine and Aging Sciences, \"G. d'Annunzio\" University of Chieti-Pescara, Chieti, Italy."}, {"Identifier": [], "Affiliation": "Center for Advanced Studies and Technology, \"G. d'Annunzio\" University of Chieti-Pescara, Chieti, Italy."}], "LastName": "Ghit", "ForeName": "Amr", "Initials": "A"}, {"Identifier": ["0000-0002-5967-2528"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Alexandria, Egypt."}, {"Identifier": [], "Affiliation": "Department of Biology, Biotechnology Program, American University in Cairo, Cairo, Egypt."}], "LastName": "Assal", "ForeName": "Dina", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Immunology, Faculty of Pharmacy, Sinai University-Kantara Branch, Ismailia, Egypt."}], "LastName": "Dorra", "ForeName": "Neamat", "Initials": "N"}, {"Identifier": ["0000-0002-3420-6168"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Alexandria, Egypt."}], "LastName": "Noby", "ForeName": "Nehad", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry Department, Faculty of Science, Alexandria University, Alexandria, Egypt."}], "LastName": "Khattab", "ForeName": "Sherine N", "Initials": "SN"}, {"Identifier": ["0000-0003-2692-5020"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Radiation Sciences Department, Medical Research Institute, University of Alexandria, Alexandria, Egypt."}], "LastName": "El Feky", "ForeName": "Shaymaa Essam", "Initials": "SE"}, {"Identifier": ["0000-0002-6887-2927"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Alexandria, Egypt. ahmed.hussein@alexu.edu.eg."}], "LastName": "Hussein", "ForeName": "Ahmed", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmacol Rep", "NlmUniqueID": "101234999", "ISSNLinking": "1734-1140"}, "ChemicalList": [{"RegistryNumber": "8XPW32PR7I", "NameOfSubstance": "astaxanthine"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Xanthophylls"}], "CommentsCorrectionsList": [{"RefSource": "Pharmacol Rep. 2023 Aug;75(4):1043. doi: 10.1007/s43440-023-00502-3", "PMID": "37308796"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Xanthophylls"}, {"QualifierName": [], "DescriptorName": "Dietary Supplements"}, {"QualifierName": [], "DescriptorName": "Nanotechnology"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Higuera-Ciapara I, F\u00e9lix-Valenzuela L, Goycoolea FM. Astaxanthin: a review of its chemistry and applications. Crit Rev Food Sci Nutr. 2006;46:185\u2013196. doi: 10.1080/10408690590957188.", "ArticleIdList": ["10.1080/10408690590957188", "16431409"]}, {"Citation": "Pashkow FJ, Watumull DG, Campbell CL. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am J Cardiol. 2008;101:58D\u201368D. doi: 10.1016/j.amjcard.2008.02.010.", "ArticleIdList": ["10.1016/j.amjcard.2008.02.010", "18474276"]}, {"Citation": "Kidd P. Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential. Altern Med Rev. 2011;16:355\u2013364.", "ArticleIdList": ["22214255"]}, {"Citation": "Guerin M, Huntley ME, Olaizola M. Haematococcus astaxanthin: applications for human health and nutrition. Trends Biotechnol. 2003;21:210\u2013216. doi: 10.1016/S0167-7799(03)00078-7.", "ArticleIdList": ["10.1016/S0167-7799(03)00078-7", "12727382"]}, {"Citation": "Ambati RR, Moi PS, Ravi S, Aswathanarayana RG. Astaxanthin: sources, extraction, stability, biological activities and its commercial applications\u2014a review. Mar Drugs. 2014;12:128\u2013152. doi: 10.3390/md12010128.", "ArticleIdList": ["10.3390/md12010128", "PMC3917265", "24402174"]}, {"Citation": "Jafari Z, Bigham A, Sadeghi S, Dehdashti SM, Rabiee N, Abedivash A, et al. Nanotechnology-abetted astaxanthin formulations in multimodel therapeutic and biomedical applications. J Med Chem. 2022;65:2\u201336. doi: 10.1021/acs.jmedchem.1c01144.", "ArticleIdList": ["10.1021/acs.jmedchem.1c01144", "PMC8762669", "34919379"]}, {"Citation": "Mart\u00ednez-\u00c1lvarez \u00d3, Calvo MM, G\u00f3mez-Estaca J. Recent advances in astaxanthin micro/nanoencapsulation to improve its stability and functionality as a food ingredient. Mar Drugs. 2020 doi: 10.3390/MD18080406.", "ArticleIdList": ["10.3390/MD18080406", "PMC7459837", "32752203"]}, {"Citation": "Rao AR, Sindhuja HN, Dharmesh SM, Sankar KU, Sarada R, Ravishankar GA. Effective inhibition of skin cancer, tyrosinase, and antioxidative properties by astaxanthin and astaxanthin esters from the green alga Haematococcus pluvialis. J Agric Food Chem. 2013;61:3842\u20133851. doi: 10.1021/jf304609j.", "ArticleIdList": ["10.1021/jf304609j", "23473626"]}, {"Citation": "Basiony M, Ouyang L, Wang D, Yu J, Zhou L, Zhu M, et al. Optimization of microbial cell factories for astaxanthin production: Biosynthesis and regulations, engineering strategies and fermentation optimization strategies. Synth Syst Biotechnol. 2022;7:689\u2013704. doi: 10.1016/j.synbio.2022.01.002.", "ArticleIdList": ["10.1016/j.synbio.2022.01.002", "PMC8866108", "35261927"]}, {"Citation": "Barros MP, Marin DP, Bolin AP, de C\u00e1ssia Santos Macedo R, Campoio TR, Fineto CJ, et al. Combined astaxanthin and fish oil supplementation improves glutathione-based redox balance in rat plasma and neutrophils. Chem Biol Interact. 2012;197:58\u201367. doi: 10.1016/j.cbi.2012.03.005.", "ArticleIdList": ["10.1016/j.cbi.2012.03.005", "22465178"]}, {"Citation": "Yaqoob Z, Arshad MS, Imran M, Munir H, Qaisrani TB, Khalid W, et al. Mechanistic role of astaxanthin derived from shrimp against certain metabolic disorders. Food Sci Nutr. 2022;10:12\u201320. doi: 10.1002/fsn3.2623.", "ArticleIdList": ["10.1002/fsn3.2623", "PMC8751436", "35035906"]}, {"Citation": "Zhang C, Chen X, Too H-P. Microbial astaxanthin biosynthesis: recent achievements, challenges, and commercialization outlook. Appl Microbiol Biotechnol. 2020;104:5725\u20135737. doi: 10.1007/s00253-020-10648-2.", "ArticleIdList": ["10.1007/s00253-020-10648-2", "32399589"]}, {"Citation": "Stachowiak B, Szulc P. Astaxanthin for the food industry. Molecules. 2021 doi: 10.3390/molecules26092666.", "ArticleIdList": ["10.3390/molecules26092666", "PMC8125449", "34063189"]}, {"Citation": "Cunningham FX, Gantt E. A portfolio of plasmids for identification and analysis of carotenoid pathway enzymes: Adonis aestivalis as a case study. Photosynth Res. 2007;92:245\u2013259. doi: 10.1007/s11120-007-9210-0.", "ArticleIdList": ["10.1007/s11120-007-9210-0", "17634749"]}, {"Citation": "Ide T, Hoya M, Tanaka T, Harayama S. Enhanced production of astaxanthin in Paracoccus sp. strain N-81106 by using random mutagenesis and genetic engineering. Biochem Eng J. 2012;65:37\u201343. doi: 10.1016/j.bej.2012.03.015.", "ArticleIdList": ["10.1016/j.bej.2012.03.015"]}, {"Citation": "Tramontin LRR, Kildegaard KR, Sudarsan S, Borodina I. Enhancement of astaxanthin biosynthesis in oleaginous yeast yarrowia lipolytica via microalgal pathway. Microorganisms. 2019 doi: 10.3390/microorganisms7100472.", "ArticleIdList": ["10.3390/microorganisms7100472", "PMC6843682", "31635020"]}, {"Citation": "Colusse GA, Duarte MER, De-Carvalho JC, Noseda MD. Chapter 7\u2014Production of astaxanthin by Haematococcus pluvialis: lab processes to scale up including the cost considerations. In: Ravishankar GA, Ranga Rao A, editors. Global perspectives on astaxanthin. Cambridge: Academic Press; 2021. pp. 121\u2013130."}, {"Citation": "Le-Feuvre R, Moraga-Suazo P, Gonzalez J, Martin SS, Henr\u00edquez V, Donoso A, et al. Biotechnology applied to Haematococcus pluvialis Fotow: challenges and prospects for the enhancement of astaxanthin accumulation. J Appl Phycol. 2020;32:3831\u20133852. doi: 10.1007/s10811-020-02231-z.", "ArticleIdList": ["10.1007/s10811-020-02231-z"]}, {"Citation": "Villar\u00f3 S, Ciardi M, Morillas-Espa\u00f1a A, S\u00e1nchez-Zurano A, Aci\u00e9n-Fern\u00e1ndez G, Lafarga T. 2021. Microalgae derived astaxanthin: research and consumer trends and industrial use as food. Foods.", "ArticleIdList": ["10.3390/foods10102303", "PMC8534595", "34681351"]}, {"Citation": "Guo J, Jones MJ, Ulrich J. Polymorphism of 3,3\u2019-dihydroxy-\u03b2, \u03b2-carotene-4,4\u2019-dione (astaxanthin) Chem Eng Res Des. 2010;88:1648\u20131652. doi: 10.1016/j.cherd.2010.02.005.", "ArticleIdList": ["10.1016/j.cherd.2010.02.005"]}, {"Citation": "Osterlie M, Bjerkeng B, Liaaen-Jensen S. Accumulation of astaxanthin all-E, 9Z and 13Z geometrical isomers and 3 and 3\u2019 RS optical isomers in rainbow trout (Oncorhynchus mykiss) is selective. J Nutr. 1999;129:391\u2013398. doi: 10.1093/jn/129.2.391.", "ArticleIdList": ["10.1093/jn/129.2.391", "10024617"]}, {"Citation": "Liu C, Zhang S, McClements DJ, Wang D, Xu Y. Design of astaxanthin-loaded core-shell nanoparticles consisting of chitosan oligosaccharides and poly(lactic-co-glycolic acid): enhancement of water solubility, stability, and bioavailability. J Agric Food Chem. 2019;67:5113\u20135121. doi: 10.1021/acs.jafc.8b06963.", "ArticleIdList": ["10.1021/acs.jafc.8b06963", "31013074"]}, {"Citation": "Jannel S, Caro Y, Bermudes M, Petit T. Novel Insights into the biotechnological production of Haematococcus pluvialis-derived astaxanthin: advances and key challenges to allow its industrial use as novel food ingredient. J Mar Sci Eng. 2020 doi: 10.3390/jmse8100789.", "ArticleIdList": ["10.3390/jmse8100789"]}, {"Citation": "Landon R, Gueguen V, Petite H, Letourneur D, Pavon-Djavid G, Anagnostou F. Impact of astaxanthin on diabetes pathogenesis and chronic complications. Mar Drugs. 2020 doi: 10.3390/md18070357.", "ArticleIdList": ["10.3390/md18070357", "PMC7401277", "32660119"]}, {"Citation": "Ahmadi A-R, Ayazi-Nasrabadi R. Astaxanthin protective barrier and its ability to improve the health in patients with COVID-19. Iran J Microbiol. 2021 doi: 10.18502/ijm.v13i4.6965.", "ArticleIdList": ["10.18502/ijm.v13i4.6965", "PMC8421583", "34557270"]}, {"Citation": "Leung LY-L, Chan SM-N, Tam H-L, Wong ES-W. Astaxanthin influence on health outcomes of adults at risk of metabolic syndrome: a systematic review and meta-analysis. Nutrients. 2022 doi: 10.3390/nu14102050.", "ArticleIdList": ["10.3390/nu14102050", "PMC9148008", "35631193"]}, {"Citation": "Visioli F, Artaria C. Astaxanthin in cardiovascular health and disease: mechanisms of action, therapeutic merits, and knowledge gaps. Food Funct. 2017;8:39\u201363. doi: 10.1039/c6fo01721e.", "ArticleIdList": ["10.1039/c6fo01721e", "27924978"]}, {"Citation": "Okada Y, Ishikura M, Maoka T. Bioavailability of astaxanthin in haematococcus algal extract: the effects of timing of diet and smoking habits. Biosci Biotechnol Biochem. 2009;73:1928\u20131932. doi: 10.1271/BBB.90078.", "ArticleIdList": ["10.1271/BBB.90078", "19734684"]}, {"Citation": "Zuluaga M, Gueguen V, Letourneur D, Pavon-Djavid G. Astaxanthin-antioxidant impact on excessive reactive oxygen species generation induced by ischemia and reperfusion injury. Chem Biol Interact. 2018;279:145\u2013158. doi: 10.1016/j.cbi.2017.11.012.", "ArticleIdList": ["10.1016/j.cbi.2017.11.012", "29179950"]}, {"Citation": "Odeberg JM, Lignell \u00c5, Pettersson A, H\u00f6glund P. Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid-based formulations. Eur J Pharm Sci. 2003;19:299\u2013304. doi: 10.1016/S0928-0987(03)00135-0.", "ArticleIdList": ["10.1016/S0928-0987(03)00135-0", "12885395"]}, {"Citation": "Singh GKS, Ismail MA, Zulkefli NAA, Mohd Affandi MMRM. Tissue distribution of astaxanthin formulation in rats. Curr Nutr Food Sci. 2018;14:329\u2013334. doi: 10.2174/1573401313666170614092146.", "ArticleIdList": ["10.2174/1573401313666170614092146"]}, {"Citation": "Park JS, Chyun JH, Kim YK, Line LL, Chew BP. Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans. Nutr Metab (Lond) 2010;7:1\u201310. doi: 10.1186/1743-7075-7-18.", "ArticleIdList": ["10.1186/1743-7075-7-18", "PMC2845588", "20205737"]}, {"Citation": "Donoso A, Gonz\u00e1lez-Dur\u00e1n J, Mu\u00f1oz AA, Gonz\u00e1lez PA, Agurto-Mu\u00f1oz C. Therapeutic uses of natural astaxanthin: an evidence-based review focused on human clinical trials. Pharmacol Res. 2021 doi: 10.1016/j.phrs.2021.105479.", "ArticleIdList": ["10.1016/j.phrs.2021.105479", "33549728"]}, {"Citation": "McClements DJ. Enhancing nutraceutical bioavailability through food matrix design. Curr Opin Food Sci. 2015;4:1\u20136. doi: 10.1016/j.cofs.2014.12.008.", "ArticleIdList": ["10.1016/j.cofs.2014.12.008"]}, {"Citation": "Fan Q, Chen Z, Wu Y, Zhu J, Yu Z. 2021. Study on the enhancement of immune function of astaxanthin from Haematococcus pluvialis. Foods.", "ArticleIdList": ["10.3390/foods10081847", "PMC8394466", "34441624"]}, {"Citation": "Fakhri S, Yosifova Aneva I, Farzaei MH, Sobarzo-S\u00e1nchez E. The neuroprotective effects of astaxanthin: therapeutic targets and clinical perspective. Molecules. 2019 doi: 10.3390/molecules24142640.", "ArticleIdList": ["10.3390/molecules24142640", "PMC6680436", "31330843"]}, {"Citation": "Lv C, Dai S, Zang J. Distribution, purification, and delivery of astaxanthin in food system-siftdesk. SDRP J Food Sci Technol. 2022 doi: 10.25177/JFST.7.2.RA.10795.", "ArticleIdList": ["10.25177/JFST.7.2.RA.10795"]}, {"Citation": "Lucks S, Muller R. Medication vehicles made of solid lipid particles (solid lipid nanospheres-SLN) 1996."}, {"Citation": "Mehnert W, M\u00e4der K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001;47:165\u2013196. doi: 10.1016/s0169-409x(01)00105-3.", "ArticleIdList": ["10.1016/s0169-409x(01)00105-3", "11311991"]}, {"Citation": "M\u00fcller RH, M\u00e4der K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery\u2014a review of the state of the art. Eur J Pharm Biopharm. 2000;50:161\u2013177. doi: 10.1016/s0939-6411(00)00087-4.", "ArticleIdList": ["10.1016/s0939-6411(00)00087-4", "10840199"]}, {"Citation": "Affandi MMM, Julianto T, Majeed A. Development and stability evaluation of astaxanthin nanoemulsion. Asian J Pharm Clin Res. 2011;4:142\u2013148."}, {"Citation": "Anarjan N, Tan CP. Physico-chemical stability of astaxanthin nanodispersions prepared with polysaccharides as stabilizing agents. Int J Food Sci Nutr. 2013;64:744\u2013748. doi: 10.3109/09637486.2013.783001.", "ArticleIdList": ["10.3109/09637486.2013.783001", "23590613"]}, {"Citation": "Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci. 2002;6:319\u2013327. doi: 10.1016/S1359-0286(02)00117-1.", "ArticleIdList": ["10.1016/S1359-0286(02)00117-1"]}, {"Citation": "Gaspar DP, Almeida AJ. Surface-functionalized lipid nanoparticles for site-specific drug delivery. In: Pathak YV, editor. Surface modification of nanoparticles for targeted drug delivery. Springer; 2019. p. 73\u201398."}, {"Citation": "M\u00fcller RH, Maassen S, Weyhers H, Mehnert W. Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. J Drug Target. 1996;4:161\u2013170. doi: 10.3109/10611869609015973.", "ArticleIdList": ["10.3109/10611869609015973", "8959488"]}, {"Citation": "Gaspar DP, Faria V, Quintas JP, Almeida AJ. Targeted delivery of lipid nanoparticles by means of surface chemical modification. Curr Org Chem. 2017;21:2360\u20132375. doi: 10.2174/1385272820666161031161101.", "ArticleIdList": ["10.2174/1385272820666161031161101"]}, {"Citation": "Michaelis K, Hoffmann MM, Dreis S, Herbert E, Alyautdin RN, Michaelis M, et al. Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain. J Pharmacol Exp Ther. 2006;317:1246\u20131253. doi: 10.1124/jpet.105.097139.", "ArticleIdList": ["10.1124/jpet.105.097139", "16554356"]}, {"Citation": "Satoh T. Chapter 38\u2014Astaxanthin: health benefits and toxicity. In: Gupta RC, editor. Nutraceuticals. Boston: Academic Press; 2016. pp. 531\u2013539."}, {"Citation": "Ekpe L, Inaku K, Ekpe V. Antioxidant effects of astaxanthin in various diseases\u2014a review. J Mol Pathophysiol. 2018;7:1. doi: 10.5455/jmp.20180627120817.", "ArticleIdList": ["10.5455/jmp.20180627120817"]}, {"Citation": "Franceschelli S, Pesce M, Ferrone A, De Lutiis MA, Patruno A, Grilli A, et al. Astaxanthin treatment confers protection against oxidative stress in U937 cells stimulated with lipopolysaccharide reducing O2-production. PLoS ONE. 2014;9:e88359. doi: 10.1371/journal.pone.0088359.", "ArticleIdList": ["10.1371/journal.pone.0088359", "PMC3919765", "24520374"]}, {"Citation": "Li H, Li J, Hou C, Li J, Peng H, Wang Q. The effect of astaxanthin on inflammation in hyperosmolarity of experimental dry eye model in vitro and in vivo. Exp Eye Res. 2020;197:108113. doi: 10.1016/j.exer.2020.108113.", "ArticleIdList": ["10.1016/j.exer.2020.108113", "32531188"]}, {"Citation": "Ohgami K, Shiratori K, Kotake S, Nishida T, Mizuki N, Yazawa K, et al. Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Invest Ophthalmol Vis Sci. 2003;44:2694\u20132701. doi: 10.1167/iovs.02-0822.", "ArticleIdList": ["10.1167/iovs.02-0822", "12766075"]}, {"Citation": "Pereira CPM, Souza ACR, Vasconcelos AR, Prado PS, Name JJ. Antioxidant and anti-inflammatory mechanisms of action of astaxanthin in cardiovascular diseases (review) Int J Mol Med. 2021;47:37\u201348. doi: 10.3892/ijmm.2020.4783.", "ArticleIdList": ["10.3892/ijmm.2020.4783", "PMC7723678", "33155666"]}, {"Citation": "Faraone I, Sinisgalli C, Ostuni A, Armentano MF, Carmosino M, Milella L, et al. Astaxanthin anticancer effects are mediated through multiple molecular mechanisms: a systematic review. Pharmacol Res. 2020;155:104689. doi: 10.1016/j.phrs.2020.104689.", "ArticleIdList": ["10.1016/j.phrs.2020.104689", "32057895"]}, {"Citation": "Kurihara H, Koda H, Asami S, Kiso Y, Tanaka T. Contribution of the antioxidative property of astaxanthin to its protective effect on the promotion of cancer metastasis in mice treated with restraint stress. Life Sci. 2002;70:2509\u20132520. doi: 10.1016/s0024-3205(02)01522-9.", "ArticleIdList": ["10.1016/s0024-3205(02)01522-9", "12173414"]}, {"Citation": "Liu X, Song M, Gao Z, Cai X, Dixon W, Chen X, et al. Stereoisomers of astaxanthin inhibit human colon cancer cell growth by inducing G2/M cell cycle arrest and apoptosis. J Agric Food Chem. 2016;64:7750\u20137759. doi: 10.1021/acs.jafc.6b03636.", "ArticleIdList": ["10.1021/acs.jafc.6b03636", "27726394"]}, {"Citation": "McCall B, McPartland CK, Moore R, Frank-Kamenetskii A, Booth BW. Effects of astaxanthin on the proliferation and migration of breast cancer cells in vitro. Antioxidants (Basel) 2018 doi: 10.3390/antiox7100135.", "ArticleIdList": ["10.3390/antiox7100135", "PMC6210693", "30287735"]}, {"Citation": "Cui L, Li Z, Xu F, Tian Y, Chen T, Li J, et al. Antitumor effects of astaxanthin on esophageal squamous cell carcinoma by up-regulation of PPAR\u03b3. Nutr Cancer. 2022;74:1399\u20131410. doi: 10.1080/01635581.2021.1952449.", "ArticleIdList": ["10.1080/01635581.2021.1952449", "34334076"]}, {"Citation": "Fakhri S, Abbaszadeh F, Dargahi L, Jorjani M. Astaxanthin: a mechanistic review on its biological activities and health benefits. Pharmacol Res. 2018;136:1\u201320. doi: 10.1016/j.phrs.2018.08.012.", "ArticleIdList": ["10.1016/j.phrs.2018.08.012", "30121358"]}, {"Citation": "Yanai H. Antihypertensive effects of astaxanthin. Integr Blood Press Control. 2008;1:1\u20133. doi: 10.2147/ibpc.s4094.", "ArticleIdList": ["10.2147/ibpc.s4094", "PMC3172056", "21949609"]}, {"Citation": "Chang MX, Xiong F. Astaxanthin and its effects in inflammatory responses and inflammation-associated diseases: recent advances and future directions. Molecules. 2020;25:1\u201314. doi: 10.3390/molecules25225342.", "ArticleIdList": ["10.3390/molecules25225342", "PMC7696511", "33207669"]}, {"Citation": "Taksima T, Chonpathompikunlert P, Sroyraya M, Hutamekalin P, Limpawattana M, Klaypradit W. Effects of astaxanthin from shrimp shell on oxidative stress and behavior in animal model of Alzheimer\u2019s disease. Mar Drugs. 2019 doi: 10.3390/md17110628.", "ArticleIdList": ["10.3390/md17110628", "PMC6891431", "31690015"]}, {"Citation": "Bahbah EI, Ghozy S, Attia MS, Negida A, Bin Emran T, Mitra S, et al. Molecular mechanisms of astaxanthin as a potential neurotherapeutic agent. Mar Drugs. 2021;19:201. doi: 10.3390/md19040201.", "ArticleIdList": ["10.3390/md19040201", "PMC8065559", "33916730"]}, {"Citation": "Qiao J, Rong L, Wang Z, Zhang M. Involvement of Akt/GSK3\u03b2/CREB signaling pathway on chronic omethoate induced depressive-like behavior and improvement effects of combined lithium chloride and astaxanthin treatment. Neurosci Lett. 2017;649:55\u201361. doi: 10.1016/j.neulet.2017.03.048.", "ArticleIdList": ["10.1016/j.neulet.2017.03.048", "28366776"]}, {"Citation": "Ke Y, Bu S, Ma H, Gao L, Cai Y, Zhang Y, et al. Preventive and therapeutic effects of astaxanthin on depressive-like behaviors in high-fat diet and streptozotocin-treated rats. Front Pharmacol. 2020 doi: 10.3389/fphar.2019.01621.", "ArticleIdList": ["10.3389/fphar.2019.01621", "PMC7003134", "32082151"]}, {"Citation": "Giannaccare G, Pellegrini M, Senni C, Bernabei F, Scorcia V, Francesco A, et al. Clinical applications of astaxanthin in the treatment of ocular diseases: emerging insights. Mar Drugs. 2020;18:239. doi: 10.3390/md18050239.", "ArticleIdList": ["10.3390/md18050239", "PMC7281326", "32370045"]}, {"Citation": "Davinelli S, Nielsen ME, Scapagnini G. Astaxanthin in skin health, repair, and disease: a comprehensive review. Nutrients. 2018;10:1\u201312. doi: 10.3390/nu10040522.", "ArticleIdList": ["10.3390/nu10040522", "PMC5946307", "29690549"]}, {"Citation": "Cort A, Ozturk N, Akpinar D, Unal M, Yucel G, Ciftcioglu A, et al. Suppressive effect of astaxanthin on retinal injury induced by elevated intraocular pressure. Regul Toxicol Pharmacol. 2010;58:121\u2013130. doi: 10.1016/J.YRTPH.2010.05.001.", "ArticleIdList": ["10.1016/J.YRTPH.2010.05.001", "20457203"]}, {"Citation": "Huang J-Y, Yeh P-T, Hou Y-C. A randomized, double-blind, placebo-controlled study of oral antioxidant supplement therapy in patients with dry eye syndrome. Clin Ophthalmol. 2016;10:813\u2013820. doi: 10.2147/OPTH.S106455.", "ArticleIdList": ["10.2147/OPTH.S106455", "PMC4869783", "27274185"]}, {"Citation": "Oslan SNH, Tan JS, Oslan SN, Matanjun P, Mokhtar RAM, Shapawi R, et al. Haematococcus pluvialis as a potential source of astaxanthin with diverse applications in industrial sectors: current research and future directions. Molecules. 2021 doi: 10.3390/molecules26216470.", "ArticleIdList": ["10.3390/molecules26216470", "PMC8587866", "34770879"]}, {"Citation": "Chalyk NE, Klochkov VA, Bandaletova TY, Kyle NH, Petyaev IM. Continuous astaxanthin intake reduces oxidative stress and reverses age-related morphological changes of residual skin surface components in middle-aged volunteers. Nutr Res. 2017;48:40\u201348. doi: 10.1016/j.nutres.2017.10.006.", "ArticleIdList": ["10.1016/j.nutres.2017.10.006", "29246280"]}, {"Citation": "Zhang X, Hou Y, Li J, Wang J, Costache V, Morales JG. The role of astaxanthin on chronic diseases. Crystals. 2021 doi: 10.3390/cryst11050505.", "ArticleIdList": ["10.3390/cryst11050505"]}, {"Citation": "Iwamoto T, Hosoda K, Hirano R, Kurata H, Matsumoto A, Miki W, et al. Inhibition of low-density lipoprotein oxidation by astaxanthin tamami of medicine introduction oxidative modification of low-density lipoprotein (LDL) has been implicated in the pathogenesis of atheroscle-rosis (1, 2). The rapid uptake of oxidative. J Atheroscler Thromb. 2000;7:216\u2013222. doi: 10.5551/jat1994.7.216.", "ArticleIdList": ["10.5551/jat1994.7.216", "11521685"]}, {"Citation": "Fassett RG, Coombes JS. Astaxanthin in cardiovascular health and disease. Molecules. 2012;17:2030\u20132048. doi: 10.3390/molecules17022030.", "ArticleIdList": ["10.3390/molecules17022030", "PMC6268807", "22349894"]}, {"Citation": "Zhang X, Hou Y, Li J, Wang J. The role of astaxanthin on chronic diseases. Crystals (Basel) 2021 doi: 10.3390/cryst11050505.", "ArticleIdList": ["10.3390/cryst11050505"]}, {"Citation": "Fakhari S, Jamzad M, Kabiri FH. Green synthesis of zinc oxide nanoparticles: a comparison. Green Chem Lett Rev. 2019;12:19\u201324. doi: 10.1080/17518253.2018.1547925.", "ArticleIdList": ["10.1080/17518253.2018.1547925"]}, {"Citation": "El-Seedi HR, El-Shabasy RM, Khalifa SAM, Saeed A, Shah A, Shah R, et al. Metal nanoparticles fabricated by green chemistry using natural extracts: biosynthesis, mechanisms, and applications. RSC Adv. 2019;9:24539\u201324559. doi: 10.1039/c9ra02225b.", "ArticleIdList": ["10.1039/c9ra02225b", "PMC9069627", "35527869"]}, {"Citation": "Nagarajan A, Sethuraman V, Balasubramani V, Sridhar TM, Sasikumar R, Vimala G. Solanum melongena leaf extract-based zinc oxide nanoparticles synthesis using green chemistry concepts. IJCA. 2020 doi: 10.56042/ijca.v59i9.41221.", "ArticleIdList": ["10.56042/ijca.v59i9.41221"]}, {"Citation": "Ratan ZA, Haidere MF, Nurunnabi Md, Shahriar SMd, Ahammad AJS, Shim YY, et al. Green chemistry synthesis of silver nanoparticles and their potential anticancer effects. Cancers (Basel) 2020 doi: 10.3390/cancers12040855.", "ArticleIdList": ["10.3390/cancers12040855", "PMC7226404", "32244822"]}, {"Citation": "Aritonang HF, Koleangan H, Wuntu AD. Synthesis of silver nanoparticles using aqueous extract of medicinal plants\u2019 (Impatiens balsamina and Lantana camara) fresh leaves and analysis of antimicrobial activity. Int J Microbiol. 2019;2019:8642303. doi: 10.1155/2019/8642303.", "ArticleIdList": ["10.1155/2019/8642303", "PMC6636566", "31354833"]}, {"Citation": "Zhaleh M, Zangeneh A, Goorani S, Seydi N, Zangeneh MM, Tahvilian R, et al. In vitro and in vivo evaluation of cytotoxicity, antioxidant, antibacterial, antifungal, and cutaneous wound healing properties of gold nanoparticles produced via a green chemistry synthesis using Gundelia tournefortii L. as a capping and reducing agent. Appl Organomet Chem. 2019;33:e5015. doi: 10.1002/aoc.5015.", "ArticleIdList": ["10.1002/aoc.5015"]}, {"Citation": "Ijaz I, Gilani E, Nazir A, Bukhari A. Detail review on chemical, physical and green synthesis, classification, characterizations and applications of nanoparticles. Green Chem Lett Rev. 2020;13:223\u2013245. doi: 10.1080/17518253.2020.1802517.", "ArticleIdList": ["10.1080/17518253.2020.1802517"]}, {"Citation": "Santonocito D, Raciti G, Campisi A, Sposito G, Panico A, Siciliano EA, et al. Astaxanthin-loaded stealth lipid nanoparticles (AST-SSLN) as potential carriers for the treatment of Alzheimer\u2019s disease: formulation development and optimization. Nanomaterials (Basel) 2021 doi: 10.3390/nano11020391.", "ArticleIdList": ["10.3390/nano11020391", "PMC7913486", "33546352"]}, {"Citation": "Zhu Y, Gu Z, Liao Y, Li S, Xue Y, Firempong MA, et al. Improved intestinal absorption and oral bioavailability of astaxanthin using poly (ethylene glycol)-graft-chitosan nanoparticles: preparation, in vitro evaluation, and pharmacokinetics in rats. J Sci Food Agric. 2022;102:1002\u20131011. doi: 10.1002/jsfa.11435.", "ArticleIdList": ["10.1002/jsfa.11435", "34312873"]}, {"Citation": "Anarjan N, Nehdi IA, Tan CP. Protection of astaxanthin in astaxanthin nanodispersions using additional antioxidants. Molecules. 2013;18:7699\u20137710. doi: 10.3390/molecules18077699.", "ArticleIdList": ["10.3390/molecules18077699", "PMC6269832", "23884122"]}, {"Citation": "Zanoni F, Vakarelova M, Zoccatelli G. Development and characterization of astaxanthin-containing whey protein-based nanoparticles. Mar Drugs. 2019 doi: 10.3390/md17110627.", "ArticleIdList": ["10.3390/md17110627", "PMC6891650", "31689914"]}, {"Citation": "Dom\u00ednguez-Hern\u00e1ndez CR, Garc\u00eda-Alvarado MA, Garc\u00eda-Galindo HS, Salgado-Cervantes MA, Berist\u00e1in CI. Stability, antioxidant activity and bioavailability of nano-emulsified astaxanthin. Rev Mex Ing Quim. 2016;15:457\u2013468. doi: 10.24275/rmiq/Alim1143.", "ArticleIdList": ["10.24275/rmiq/Alim1143"]}, {"Citation": "Kim D-M, Hyun S-S, Yun P, Lee C-H, Byun S-Y. Identification of an emulsifier and conditions for preparing stable nanoemulsions containing the antioxidant astaxanthin. Int J Cosmet Sci. 2012;34:64\u201373. doi: 10.1111/j.1468-2494.2011.00682.x.", "ArticleIdList": ["10.1111/j.1468-2494.2011.00682.x", "21883294"]}, {"Citation": "Tachaprutinun A, Udomsup T, Luadthong C, Wanichwecharungruang S. Preventing the thermal degradation of astaxanthin through nanoencapsulation. Int J Pharm. 2009;374:119\u2013124. doi: 10.1016/j.ijpharm.2009.03.001.", "ArticleIdList": ["10.1016/j.ijpharm.2009.03.001", "19446768"]}, {"Citation": "Ge S, Jia R, Li Q, Liu W, Liu M, Cai D, et al. Pickering emulsion stabilized by zein/Adzuki bean seed coat polyphenol nanoparticles to enhance the stability and bioaccessibility of astaxanthin. J Funct Foods. 2022;88:104867. doi: 10.1016/j.jff.2021.104867.", "ArticleIdList": ["10.1016/j.jff.2021.104867"]}, {"Citation": "Rodriguez-Ruiz V, Salatti-Dorado J\u00c1, Barzegari A, Nicolas-Boluda A, Houaoui A, Caballo C, et al. Astaxanthin-loaded nanostructured lipid carriers for preservation of antioxidant activity. Molecules. 2018 doi: 10.3390/molecules23102601.", "ArticleIdList": ["10.3390/molecules23102601", "PMC6222411", "30314284"]}, {"Citation": "Wang Q, Zhao Y, Guan L, Zhang Y, Dang Q, Dong P, et al. Preparation of astaxanthin-loaded DNA/chitosan nanoparticles for improved cellular uptake and antioxidation capability. Food Chem. 2017;227:9\u201315. doi: 10.1016/j.foodchem.2017.01.081.", "ArticleIdList": ["10.1016/j.foodchem.2017.01.081", "28274463"]}, {"Citation": "Wang T, Hu Q, Lee J-Y, Luo Y. Solid lipid-polymer hybrid nanoparticles by in situ conjugation for oral delivery of astaxanthin. J Agric Food Chem. 2018;66:9473\u20139480. doi: 10.1021/acs.jafc.8b02827.", "ArticleIdList": ["10.1021/acs.jafc.8b02827", "30130387"]}, {"Citation": "Lu Z, Long Y, Li J, Li J, Ren K, Zhao W, et al. Simultaneous inhibition of breast cancer and its liver and lung metastasis by blocking inflammatory feed-forward loops. J Control Rel. 2021;338:662\u2013679. doi: 10.1016/j.jconrel.2021.08.047.", "ArticleIdList": ["10.1016/j.jconrel.2021.08.047", "34478751"]}, {"Citation": "Haung H-Y, Wang Y-C, Cheng Y-C, Kang W, Hu S-H, Liu D, et al. A novel oral astaxanthin nanoemulsion from Haematococcus pluvialis induces apoptosis in lung metastatic melanoma. Oxid Med Cell Longev. 2020;2020:2647670. doi: 10.1155/2020/2647670.", "ArticleIdList": ["10.1155/2020/2647670", "PMC7471791", "32908627"]}, {"Citation": "Hu F, Liu W, Yan L, Kong F, Wei K. Optimization and characterization of poly (lactic-co-glycolic acid) nanoparticles loaded with astaxanthin and evaluation of anti-photodamage effect in vitro. R Soc Open Sci. 2019;6:191184. doi: 10.1098/rsos.191184.", "ArticleIdList": ["10.1098/rsos.191184", "PMC6837188", "31824727"]}, {"Citation": "Zhang X-S, Zhang X, Zhou M-L, Zhou X-M, Li N, Li W, et al. Amelioration of oxidative stress and protection against early brain injury by astaxanthin after experimental subarachnoid hemorrhage. J Neurosurg. 2014;121:42\u201354. doi: 10.3171/2014.2.JNS13730.", "ArticleIdList": ["10.3171/2014.2.JNS13730", "24724856"]}, {"Citation": "Chen Y, Tie S, Zhang X, Zhang L, Tan M. Preparation and characterization of glycosylated protein nanoparticles for astaxanthin mitochondria targeting delivery. Food Funct. 2021;12:7718\u20137727. doi: 10.1039/d1fo01751a.", "ArticleIdList": ["10.1039/d1fo01751a", "34286807"]}, {"Citation": "Bharathiraja S, Manivasagan P, Oh Y-O, Moorthy MS, Seo H, Bui NQ, et al. Astaxanthin conjugated polypyrrole nanoparticles as a multimodal agent for photo-based therapy and imaging. Int J Pharm. 2017;517:216\u2013225. doi: 10.1016/j.ijpharm.2016.12.020.", "ArticleIdList": ["10.1016/j.ijpharm.2016.12.020", "27956193"]}, {"Citation": "Gu J, Chen Y, Tong L, Wang X, Yu D, Wu H. Astaxanthin-loaded polymer-lipid hybrid nanoparticles (ATX-LPN): assessment of potential otoprotective effects. J Nanobiotechnol. 2020;18:53. doi: 10.1186/s12951-020-00600-x.", "ArticleIdList": ["10.1186/s12951-020-00600-x", "PMC7081530", "32192504"]}, {"Citation": "Hama S, Takahashi K, Inai Y, Shiota K, Sakamoto R, Yamada A, et al. Protective effects of topical application of a poorly soluble antioxidant astaxanthin liposomal formulation on ultraviolet-induced skin damage. J Pharm Sci. 2012;101:2909\u20132916. doi: 10.1002/jps.23216.", "ArticleIdList": ["10.1002/jps.23216", "22628205"]}, {"Citation": "You Z-Q, Wu Q, Zhou X-M, Zhang X-S, Yuan B, Wen L-L, et al. Receptor-mediated delivery of astaxanthin-loaded nanoparticles to neurons: an enhanced potential for subarachnoid hemorrhage treatment. Front Neurosci. 2019;13:989. doi: 10.3389/fnins.2019.00989.", "ArticleIdList": ["10.3389/fnins.2019.00989", "PMC6759683", "31619957"]}, {"Citation": "Hu Q, Hu S, Fleming E, Lee J-Y, Luo Y. Chitosan-caseinate-dextran ternary complex nanoparticles for potential oral delivery of astaxanthin with significantly improved bioactivity. Int J Biol Macromol. 2020;151:747\u2013756. doi: 10.1016/j.ijbiomac.2020.02.170.", "ArticleIdList": ["10.1016/j.ijbiomac.2020.02.170", "32084488"]}, {"Citation": "Zhang J, Peng C-A. Enhanced proliferation and differentiation of mesenchymal stem cells by astaxanthin-encapsulated polymeric micelles. PLoS ONE. 2019;14:e0216755. doi: 10.1371/journal.pone.0216755.", "ArticleIdList": ["10.1371/journal.pone.0216755", "PMC6527225", "31107886"]}, {"Citation": "Chang X, Xing L, Wang Y, Yang C-X, He Y-J, Zhou T-J, et al. Monocyte-derived multipotent cell delivered programmed therapeutics to reverse idiopathic pulmonary fibrosis. Sci Adv. 2020;6:eaba3167. doi: 10.1126/sciadv.aba3167.", "ArticleIdList": ["10.1126/sciadv.aba3167", "PMC7253157", "32518825"]}, {"Citation": "Chen Z, Li W, Shi L, Jiang L, Li M, Zhang C, et al. Kidney-targeted astaxanthin natural antioxidant nanosystem for diabetic nephropathy therapy. Eur J Pharm Biopharm. 2020;156:143\u2013154. doi: 10.1016/j.ejpb.2020.09.005.", "ArticleIdList": ["10.1016/j.ejpb.2020.09.005", "32937179"]}, {"Citation": "Shanmugapriya K, Kim H, Saravana PS, Chun B-S, Kang HW. Astaxanthin-alpha tocopherol nanoemulsion formulation by emulsification methods: Investigation on anticancer, wound healing, and antibacterial effects. Colloids Surf B Biointerfaces. 2018;172:170\u2013179. doi: 10.1016/j.colsurfb.2018.08.042.", "ArticleIdList": ["10.1016/j.colsurfb.2018.08.042", "30172200"]}, {"Citation": "Shanmugapriya K, Kim H, Kang HW. A new alternative insight of nanoemulsion conjugated with \u03ba-carrageenan for wound healing study in diabetic mice: In vitro and in vivo evaluation. Eur J Pharm Sci. 2019;133:236\u2013250. doi: 10.1016/j.ejps.2019.04.006.", "ArticleIdList": ["10.1016/j.ejps.2019.04.006", "30965083"]}, {"Citation": "Madhavi D, Kagan D, Seshadri S. A study on the bioavailability of a proprietary, sustained-release formulation of astaxanthin. Integr Med A Clin J. 2018;17(3):38.", "ArticleIdList": ["PMC6396763", "30962794"]}, {"Citation": "Bahadar H, Maqbool F, Niaz K, Abdollahi M. Toxicity of nanoparticles and an overview of current experimental models. Iran Biomed J. 2016;20:1\u201311. doi: 10.7508/ibj.2016.01.001.", "ArticleIdList": ["10.7508/ibj.2016.01.001", "PMC4689276", "26286636"]}, {"Citation": "Zeb A, Rana I, Choi H-I, Lee C-H, Baek S-W, Lim C-W, et al. Potential and applications of nanocarriers for efficient delivery of biopharmaceuticals. Pharmaceutics. 2020 doi: 10.3390/pharmaceutics12121184.", "ArticleIdList": ["10.3390/pharmaceutics12121184", "PMC7762162", "33291312"]}, {"Citation": "Mohajerani A, Burnett L, Smith JV, Kurmus H, Milas J, Arulrajah A, et al. Nanoparticles in construction materials and other applications, and implications of nanoparticle use. Materials. 2019 doi: 10.3390/ma12193052.", "ArticleIdList": ["10.3390/ma12193052", "PMC6804222", "31547011"]}, {"Citation": "Istiqola A, Syafiuddin A. A review of silver nanoparticles in food packaging technologies: regulation, methods, properties, migration, and future challenges. J Chin Chem Soc. 2020;67:1942\u20131956. doi: 10.1002/jccs.202000179.", "ArticleIdList": ["10.1002/jccs.202000179"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "2", "Day": "25"}, {"Year": "2023", "Month": "4", "Day": "13"}, {"Year": "2023", "Month": "4", "Day": "12"}, {"Year": "2023", "Month": "7", "Day": "28", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "5", "Day": "14", "Hour": "1", "Minute": "7"}, {"Year": "2023", "Month": "5", "Day": "13", "Hour": "23", "Minute": "3"}, {"Year": "2023", "Month": "5", "Day": "13"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37179259", "PMC10182848", "10.1007/s43440-023-00488-y", "10.1007/s43440-023-00488-y"]}}], "PubmedBookArticle": []}